CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C08804 | BRD-K20146413 | BRD-K20146413 | -- | -- | -- | Details |
| C08805 | BRD-K20148542 | BRD-K20148542 | -- | -- | -- | Details |
| C08806 | BRD-K20151898 | BRD-K20151898 | -- | -- | -- | Details |
| C08807 | BRD-K20152659 | BRD-K20152659 | -- | -- | dihomo-gamma-linolenic-acid | Details |
| C08808 | BRD-K20154295 | BRD-K20154295 | -- | -- | -- | Details |
| C08809 | BRD-K20157822 | BRD-K20157822 | -- | -- | -- | Details |
| C08810 | BRD-K20159808 | BRD-K20159808 | -- | -- | -- | Details |
| C08811 | BRD-K20160406 | BRD-K20160406 | -- | -- | -- | Details |
| C08812 | BRD-K20163346 | BRD-K20163346 | -- | -- | -- | Details |
| C08813 | BRD-K20168442 | vecuronium | CHRNA2 | Acetylcholine receptor antagonist | -- | Details |
| C08814 | BRD-K20168484 | BRD-K20168484 | ALOX5AP | Lipoxygenase inhibitor | -- | Details |
| C08815 | BRD-K20170530 | BRD-K20170530 | -- | -- | -- | Details |
| C08816 | BRD-K20171002 | BRD-K20171002 | -- | -- | -- | Details |
| C08817 | BRD-K20178228 | BRD-K20178228 | -- | -- | -- | Details |
| C08818 | BRD-K20182751 | BRD-K20182751 | -- | -- | -- | Details |
| C08819 | BRD-K20183527 | BRD-K20183527 | -- | -- | -- | Details |
| C08820 | BRD-K20184768 | BRD-K20184768 | -- | -- | -- | Details |
| C08821 | BRD-K20185935 | BRD-K20185935 | -- | -- | -- | Details |
| C08822 | BRD-K20191348 | BRD-K20191348 | -- | -- | -- | Details |
| C08823 | BRD-K20192397 | BRD-K20192397 | -- | -- | -- | Details |
| C08824 | BRD-K20196153 | BRD-K20196153 | -- | -- | -- | Details |
| C08825 | BRD-K20197062 | SA-94315 | CASP3 | Caspase inhibitor | -- | Details |
| C08826 | BRD-K20197338 | BRD-K20197338 | -- | -- | -- | Details |
| C08827 | BRD-K20199304 | BRD-K20199304 | -- | -- | -- | Details |
| C08828 | BRD-K20200700 | BRD-K20200700 | -- | -- | -- | Details |
| C08829 | BRD-K20203275 | BRD-K20203275 | -- | -- | -- | Details |
| C08830 | BRD-K20203758 | BRD-K20203758 | -- | -- | -- | Details |
| C08831 | BRD-K20211345 | BRD-K20211345 | -- | -- | -- | Details |
| C08832 | BRD-K20215591 | BRD-K20215591 | -- | -- | -- | Details |
| C08833 | BRD-K20216424 | BRD-K20216424 | -- | -- | -- | Details |
| C08834 | BRD-K20220643 | BRD-K20220643 | -- | -- | -- | Details |
| C08835 | BRD-K20231471 | BRD-K20231471 | -- | -- | -- | Details |
| C08836 | BRD-K20236423 | BRD-K20236423 | -- | -- | -- | Details |
| C08837 | BRD-K20245846 | BRD-K20245846 | -- | -- | -- | Details |
| C08838 | BRD-K20251969 | BRD-K20251969 | -- | -- | -- | Details |
| C08839 | BRD-K20253608 | BRD-K20253608 | -- | -- | -- | Details |
| C08840 | BRD-K20255967 | BRD-K20255967 | -- | -- | -- | Details |
| C08841 | BRD-K20259776 | BRD-K20259776 | -- | -- | -- | Details |
| C08842 | BRD-K20264945 | BRD-K20264945 | -- | -- | -- | Details |
| C08843 | BRD-K20271299 | BRD-K20271299 | -- | -- | -- | Details |
| C08844 | BRD-K20271744 | BRD-K20271744 | -- | -- | -- | Details |
| C08845 | BRD-K20272026 | BRD-K20272026 | -- | -- | -- | Details |
| C08846 | BRD-K20278539 | BRD-K20278539 | -- | -- | -- | Details |
| C08847 | BRD-K20278954 | BRD-K20278954 | -- | -- | -- | Details |
| C08848 | BRD-K20281332 | BRD-K20281332 | -- | -- | -- | Details |
| C08849 | BRD-K20284960 | BRD-K20284960 | -- | -- | -- | Details |
| C08850 | BRD-K20285085 | fostamatinib | SYK | Syk inhibitor; FLT3 inhibitor | -- | Details |
| C08851 | BRD-K20287671 | SU-4312 | KDR | PDGFR inhibitor; VEGFR inhibitor; Tyrosine kinase inhibitor | -- | Details |
| C08852 | BRD-K20288742 | BRD-K20288742 | -- | -- | -- | Details |
| C08853 | BRD-K20290250 | BIX-02188 | -- | -- | -- | Details |
| C08854 | BRD-K20300606 | BRD-K20300606 | -- | -- | -- | Details |
| C08855 | BRD-K20307883 | BRD-K20307883 | -- | -- | -- | Details |
| C08856 | BRD-K20310932 | BRD-K20310932 | -- | -- | -- | Details |
| C08857 | BRD-K20313525 | rosmarinic-acid | -- | -- | -- | Details |
| C08858 | BRD-K20315727 | BRD-K20315727 | -- | -- | -- | Details |
| C08859 | BRD-K20329507 | BRD-K20329507 | -- | -- | -- | Details |
| C08860 | BRD-K20331065 | BRD-K20331065 | -- | -- | -- | Details |
| C08861 | BRD-K20332819 | BRD-K20332819 | -- | -- | -- | Details |
| C08862 | BRD-K20332840 | BRD-K20332840 | -- | -- | -- | Details |
| C08863 | BRD-K20338176 | cefaclor | -- | -- | -- | Details |
| C08864 | BRD-K20342806 | BRD-K20342806 | -- | -- | -- | Details |
| C08865 | BRD-K20342961 | BRD-K20342961 | -- | -- | -- | Details |
| C08866 | BRD-K20344910 | triphenylphosphine-oxide | -- | -- | -- | Details |
| C08867 | BRD-K20345035 | BRD-K20345035 | -- | -- | -- | Details |
| C08868 | BRD-K20347026 | BRD-K20347026 | -- | -- | -- | Details |
| C08869 | BRD-K20347745 | BRD-K20347745 | -- | -- | -- | Details |
| C08870 | BRD-K20348534 | BRD-K20348534 | -- | -- | -- | Details |
| C08871 | BRD-K20351658 | BRD-K20351658 | -- | -- | -- | Details |
| C08872 | BRD-K20352452 | BRD-K20352452 | -- | -- | -- | Details |
| C08873 | BRD-K20355073 | BRD-K20355073 | -- | -- | -- | Details |
| C08874 | BRD-K20361257 | BRD-K20361257 | -- | -- | -- | Details |
| C08875 | BRD-K20368781 | BRD-K20368781 | -- | -- | -- | Details |
| C08876 | BRD-K20369357 | BRD-K20369357 | -- | -- | -- | Details |
| C08877 | BRD-K20372197 | droxidopa | ADRA1D; ADRA1B; ADRA1A; ADRA2A; ADRA2B; ADRA2C; ADRB1; ADRB2; ADRB3 | Norepinephrine precursor | -- | Details |
| C08878 | BRD-K20373726 | BRD-K20373726 | -- | -- | -- | Details |
| C08879 | BRD-K20377072 | BRD-K20377072 | -- | -- | -- | Details |
| C08880 | BRD-K20381303 | BRD-K20381303 | -- | -- | -- | Details |
| C08881 | BRD-K20382089 | BRD-K20382089 | -- | -- | -- | Details |
| C08882 | BRD-K20398543 | BRD-K20398543 | -- | -- | -- | Details |
| C08883 | BRD-K20401833 | BRD-K20401833 | RORA | ROR inverse agonist | -- | Details |
| C08884 | BRD-K20415826 | BRD-K20415826 | -- | -- | -- | Details |
| C08885 | BRD-K20416270 | BRD-K20416270 | -- | -- | -- | Details |
| C08886 | BRD-K20420220 | BRD-K20420220 | -- | -- | -- | Details |
| C08887 | BRD-K20426211 | BRD-K20426211 | -- | -- | -- | Details |
| C08888 | BRD-K20428189 | BRD-K20428189 | -- | -- | -- | Details |
| C08889 | BRD-K20428479 | BRD-K20428479 | -- | -- | -- | Details |
| C08890 | BRD-K20429911 | BRD-K20429911 | -- | -- | -- | Details |
| C08891 | BRD-K20433775 | BRD-K20433775 | -- | -- | -- | Details |
| C08892 | BRD-K20435953 | BRD-K20435953 | -- | -- | -- | Details |
| C08893 | BRD-K20437312 | BRD-K20437312 | -- | -- | -- | Details |
| C08894 | BRD-K20440082 | BRD-K20440082 | -- | -- | -- | Details |
| C08895 | BRD-K20441249 | BRD-K20441249 | -- | -- | -- | Details |
| C08896 | BRD-K20447569 | BRD-K20447569 | -- | -- | -- | Details |
| C08897 | BRD-K20449903 | BRD-K20449903 | -- | -- | -- | Details |
| C08898 | BRD-K20451745 | BRD-K20451745 | -- | -- | -- | Details |
| C08899 | BRD-K20454972 | BRD-K20454972 | -- | -- | -- | Details |
| C08900 | BRD-K20462402 | BRD-K20462402 | -- | -- | -- | Details |
| C08901 | BRD-K20463415 | LY-2606368 | -- | -- | -- | Details |
| C08902 | BRD-K20469405 | BRD-K20469405 | -- | -- | -- | Details |
| C08903 | BRD-K20470077 | BRD-K20470077 | -- | -- | -- | Details |